Cancer therapy research to benefit from supercomputer award
26 March 2013
×î×¼µÄÁùºÏ²ÊÂÛ̳ researchers studying molecular cancer therapies are using top US supercomputers to accelerate their work.
Professor Peter Coveney, Dr Flemming Hansen, Dr Dave Wright, Dr Shunzhou Wan & Mr Micha Kunze (×î×¼µÄÁùºÏ²ÊÂÛ̳ Chemistry) have been investigating potential targets for novel cancer therapies. Access to ANTON will enable the team to simulate protein-folding mechanisms in order to identify proteins that could be targeted by new drug therapies.
ANTON, developed by the DE Shaw Group, is the world's fastest supercomputer for performing protein-folding and related biomolecular simulations. The award runs for three years, is for over 8 days of consecutive computing time at the Pittsburg Supercomputing Center, with an equivalent value of approximately £250,000.
The proposal was written by Micha Kunze, Dr David Wright, Dr Flemming Hansen and Professor Peter Coveney, and forms a centrepiece of Micha's Wellcome Trust-funded PhD research.